GSK Investigational Site
Bangalore, 560034, India
NCT Number: NCT02254460
The present study supplements iron as part of multiple micro-nutrient supplementation to demonstrate that intake of a micronutrient fortified powder in milk helps increase the uptake of key micronutrients like iron due to unique nature of the given matrix, as compared to intake of iron alone in milk.
Looking for future studies?
Notify Me7 year–10 year
All sexes
Interventional
Not applicable
Bangalore, 560034, India
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Experimental product: Micronutrient fortified beverage powder, packed as 27 g individual sachet, administered orally as a single serve.
Energy equivalent beverage powder without micronutrient fortification, packed as 27 g individual sachets, administered orally as a single serve
Time frame: Day 15
Iron uptake was measured using stable isotopes of 57Fe and 58Fe to label the test and control products. Fractional iron absorption levels of 57Fe and 58Fe were calculated, to give a direct measure of the iron uptake from each of the study treatments.
GlaxoSmithKline
Industry
A Double Blind, Randomized, Two-way Cross-over Study to Investigate the Uptake of Iron From Micronutrient Fortified Powder vs. From Tailored Control in Milk.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02338609
Body Weight, Growth and Development
Los Angeles, California, United States
View Trial DetailsNCT04624347
Dyssomnias, Female Urogenital Diseases and Pregnancy Complications
Rennes, Brittany Region, France
View Trial DetailsNCT02542865
Growth and Development
Pune, India
View Trial DetailsNCT03519503
Growth and Development
Ouagadougou, Burkina Faso
View Trial Details